Location: New Orleans, United States
Date: June 10 to June 14
76th Scientific Session.
LEADER and EMPA-REG Trials
BNP Enhances Predictive Models of Cardiovascular Outcomes in Patients with Type 2 Diabetes and a Recent Coronary Event; ELIXA Trial
Update from EMPA-REG Outcome Trial: Clinical implications - A Cardiologist's Perspective
Update from EMPA-REG Outcome Trial: Microvascular outcomes
LEADER Trial - Safety